|
Back to EZorb Newsletter Index |
|
In this issue:
Letter I: From Karen T. Hi, my name is Karen T. I was diagnosed for osteoporosis 6 years ago. And I've been using Fosomax ever since while my bone density continued decline. Five months ago my doctor wanted to switch me to Prolia shots. I was shocked to find out there were so many side effects. No way I was gonna use it. I found out about EZorb on the internet. I read all the reviews and decided to give it a try. All my life I'm used to do what my doctors told me to do. So I felt a little uneasy at the beginning. I can only do bone scan once every other year - so that's a huge commitment. About 6 or 7 weeks on EZorb, my husband said it might be working because I walked more steady. Then I realized I don't have pain no more in my right hip. I've had arthritic problems in my hip for at least 10 years now. Doctor said there's no cure so I just learn to live with the pain. It's been 4 months now. I have no pain in the hip and my back is not as tight as before. I give all the credit to EZorb. I can't wait for my next bone scan! Thank you. Letter II: From Emma R. My main issue was a very, very painful heel spur on left foot. I went to see a podiatrist, did several remedies. It worked temporarily for short time but got worst when I missed those tx routines. Don't have time to do all that. I have been diagnosed with calcium deficiency, so I guess it's expected. I took several kinds of dietary supplements since I opposed taking too much meds due to negative effects on my liver. Those did not work either. The pain was excruciating everyday that I can't walk normal, always limping even with a special sole inside my shoes. I can't just get up and walk. I have to wait awhile do little massage on my foot before I start walking. Then I found this post in FB, about the Ezorb. I did research at first, then I liked their findings. I ordered 3 bottles. On the first 3 days, saw results right away. But then everyday pain still there, but because their literatures stated in 3mos, I will see big difference, so I continued and watch/monitor results. I am now about to complete 3 mos and saw big, big difference. I already ordered my next supplies and will continue, this is the only calcium/dietary supplement that really worked. Thank you! From the Desk of EZorb Newsletter Editor:This newsletter is now read by over 120,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's life. Please email your story to sharesuccess @ ezorbonline.com or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public. 2. Research News: Type 2 Diabetes Associated with Higher Risk of Nonvascular ComorbiditiesA large study of data from people with type 2 diabetes in general practice reveals that non-cardiovascular (CVD) comorbidities such as osteoarthritis and depression are common, and significantly more so than in people without diabetes. “Defining patterns of multimorbidity can have important clinical applications such as identifying potentially harmful drug-disease interactions, establishing optimal targeting of specific therapies, and implementing individualized management plans around the time of diagnosis,” say the researchers. Salwa Zghebi (University of Manchester, UK) and co-researchers examined patient data from 391 English general practices in the Clinical Practice Research Datalink for 18 physical and mental health morbidities. They found that 76.7% of 108,588 people with type 2 diabetes had at least one of these comorbidities, compared with 54.2% of 528,667 controls without diabetes who were matched for age, gender and general practice. As expected, CVD was highly prevalent - with hypertension being the most common condition in both groups - and was significantly more common among people with diabetes than controls. In particular, they had a more than twofold increased likelihood of having hypertension, myocardial infarction, heart failure, and peripheral vascular disease. But the team also identified a number of non-CVD conditions with a high prevalence in people with diabetes, namely osteoarthritis (18.4%), depression (12.4%), asthma (8.5%), hypothyroidism (6.7%), chronic obstructive pulmonary disease (5.9%), and anxiety (5.6%). All of these conditions were significantly more likely to occur in people with diabetes than those without, but the researchers also highlight schizophrenia, which although one of the least common conditions overall, was 2.38-fold more likely to occur among people with diabetes than the controls. “Prior research has mainly focused on patterns of cardiovascular disease in people with type 2 diabetes resulting in little understanding of trends of a broader range of important comorbidities in people with and without type 2 diabetes,” write the researchers in BMJ Open. They add that non-CVD comorbidities rarely feature in guidelines for type 2 diabetes management. Among people with type 2 diabetes, comorbidities overall were more common in women than men, with hypothyroidism in particular being around four times higher. Comorbidity prevalence increased with older age in people with diabetes but remained higher than in controls in all age groups. The exceptions were asthma and anxiety, which remained stable across age groups, and depression, which was more common in people aged 55 years or younger than in older people. Stressing that depression was a common finding overall, the team says this “highlights a profound clinical need in young people who could benefit enormously from mental health intervention.” Original research was published in BMJ Open 2020; 10: e033866. 3. Useful LinksEZorb - Frequently Asked Questions & Answers 4. What Are Others Saying About EZorb and Marvlix?EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families
around the world. Click here to read what people say about EZorb
and Marvlix. |
|
Back to EZorb Newsletter Index |